GENOMENEXT
GenomeNext delivers an automated genomic analysis solution that provides researchers and clinicians with a real-time, secure and regulatory compliant environment to analyze genomic data. The GenomeNext analysis pipeline is the first comprehensive solution that can deliver accurate, reproducible and determinate genomic analysis results, from FASTQ to VCF to annotation in under 3 hours for whole genomes, under 1 hour per exome and 30 minutes per panel. GenomeNext delivers an automated genomic a... nalysis solution that provides researchers and clinicians with a real-time, secure and regulatory compliant environment to analyze genomic data. The GenomeNext analysis pipeline is the first comprehensive solution that can deliver accurate, reproducible and determinate genomic analysis results, from FASTQ to VCF to annotation in under 2 hours for whole genomes, under 1 hour per exome and 30 minutes per panel. Our proprietary algorithm powers a streamlined analysis platform delivering deterministic analyses to ensure your results are accurate and reproducible the first time and every time. Our analysis pipeline follows the commonly accepted best practices for both single sample and multisample variant discovery by performing alignment, deduplication, local realignment around indels, base quality score recalibration, variant calling and genotyping. Each step of the GenomeNext analysis pipeline has been carefully architected to rapidly align raw sequence reads to a reference genome, refine this alignment in areas where it is known that aligners can have difficulties, clean up lab prep and sequencer-related artifacts, and perform discovery of variants and genotypes with a high degree of confidence. GenomeNext automated analysis platform features: -Run exomes, targeted panels, and whole genomes -Run multiple samples in one analysis request -Analysis results in under 2 hours -100% Reproducible and Deterministic Results -Immediate download of VCF and Annotation files -Visualization of analyzed data -Cost-effective solution for clinical and research needs -Regulatory compliant platform -Enables population scale genomics -Secure storage of large genomic data -Secure platform that can be accessed from anywhere in the world -Reduce computational bottleneck -Collaboration platform for teams -Unlimited user accounts with access control features.
GENOMENEXT
Industry:
Biotechnology Genetics
Founded:
2014-03-15
Address:
Columbus, Ohio, United States
Country:
United States
Website Url:
http://www.genomenext.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.2 M USD
Technology used in webpage:
Apache YouTube ASP.NET IIS DigiCert SSL ASP.NET 4.0 Amazon SSL IIS 8 Digital Ocean ASP.NET MVC
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Founder
Investors List
Hydra Capital
Hydra Capital investment in Seed Round - GenomeNext
Official Site Inspections
http://www.genomenext.com
- Host name: 164.90.244.158
- IP address: 164.90.244.158
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013